Praising Uttar Pradesh Yogi Adityanath for his good governance in taking the state to new heights, Prime Minister Modi said, "I am very happy. Further, driverless trains are to be introduced along with the Communication Based Train Control (CBTC) signalling technology, which would facilitate the movement of trains within a frequency of 90 to 100 seconds.

The Magenta Line also marks the usage of the first platform screen doors (PSDs), which are glass-made screens installed near the edge of platforms that open only when a train arrives and shut after it departs. Driven by blind faith and superstition, leaders never went to places for decades.The 12."We live in an era in which connectivity is all important. This metro, whose line was just inaugurated, is not only for the present but also for future generations," he said."We have changed these mindsets.

This was a historic moment. How unfortunate is that! Unfortunately, there were superstitions associated with Noida and in his own style, Yogi Adityanath has risen above these superstitions and has come to Noida," he added. Earlier, the governments took pride in making new laws. We said we wanted to be the Government that removes laws that are obsolete. 24th December 2002. I thank Prime Minister Narendra Modi for giving Uttar Pradesh the offering of this new metro line on this occasion," Adityanath further said. Due to his dress, few people find it fashionable to believe he is not modern enough but it is Yogi Adityanath Ji who has done what the other chief ministers of Uttar Pradesh could not - he has come to Noida.Conveying his greetings on the occasion of Christmas, Prime Minister Modi took the chance to commemorate the birth anniversary of "two Bharat Ratnas" - Indian educationist and freedom fighter Madan Mohan Malviya and former prime minister Atal Bihari Vajpayee.Acknowledging the role of the people of Uttar Pradesh in strengthening the country, Prime Minister Modi said, "It is due to the people of Uttar Pradesh that the nation has got a strong and stable government.. Prime Minister Modi, along with Adityanath, also travelled on a patch of the new route - from Noida to the Okhla Bird Sanctuary station.The coaches will reportedly have an LED display, power charging capacity and colourful seats, while the stations will portray themes of nature, yoga, and cultural landmarks. Since then, the metro network in NCR has expanded considerably," he added.Speaking at the inaugural ceremony of the metro line in Noida, the chief minister said, "This step to inaugurate Metros magenta line will prove to be a milestone towards realising the dreams of development for the Noida and the Greater Noida region. In order to achieve this, state of the art mass transit systems are the need of the hour.

He added the Uttar Pradesh Government would soon bring new metro lines in Kanpur and Agra as well.Atal Bihari Vajpayee Ji took the ride on the metro.Addressing the gathering in Noida, Prime Minister Modi said the just-inaugurated metro line was not only for the present, but also for future generations.I would go to all those places in my first year itself."When I became the structural rivets chief minister, people told me of a few places where no chief ministers went because they were inauspicious. For us, decisions are about national interest and not political gains. I was clear. ( Photo: ANI | Twitter) Noida: Soon after inaugurating a stretch of the new Magenta line of the Delhi Metro, Prime Minister Narendra Modi on Monday said the development of the railway and road infrastructure was happening at a historic pace under the government at the Centre."Prime Minister Modi further said if anybody thought not going to a place would prolong their chief ministerial tenure and visiting a place would curtail it, such a person did not deserve to be a chief minister. India, Uttar Pradesh, Noida.Prime Minister Modi, along with Adityanath, also travelled on a patch of the new route - from Noida to the Okhla Bird Sanctuary station.Uttar Pradesh Chief Minister Yogi Adityanath on Monday said the step to inaugurate a stretch of the new Magenta line of the Delhi Metro would prove to be a milestone towards development of Noida and Greater Noida.. I will always remain grateful to UP for their affection..Dreaming to live in an India in which the petrol imports reduce, Prime Minister Modi said that in order to achieve this, state of the art mass transit systems were the need of the hour."In 2022, when we mark 75 years of freedom, I dream that we live in an India in which our petrol imports reduce.."Today is Christmas and it is also the birth anniversary of former prime minister Atal Bihari Vajpayee.64-km stretch runs between Kalkaji and Noidas Botanical Garden and accounts for a travel time of 19 minutes, thus facilitating easy access for commuters from South Delhi to Noida, and vice versa.

Good governance cant happen when outdated laws hamper decision making," he added.Addressing the gathering in Noida, PM Modi said the just-inaugurated metro line was not only for present, but also for future generations."He further said that governance cannot happen when the dominant thought process begins at Mera Kya and ends at Mujhe Kya, adding it was important for governments to do away with outdated laws that hamper the growth of the nation

Hide Comments | Add Comment

Related StoriesStudy finds stem cell therapy may be used to reverse diabetesHeart failure may be treated by umbilical cord stem cells, says studyHuman stem cells restore mobility in monkeys with Parkinson&Stainless Steel Rivet Nuts Manufacturers039;s. Ken Uchino, a leading Multistem investigator from Cleveland Clinic.Athersys Inc and Mesoblast Ltd, are beginning final stage trials on patients that could change course of devastating stroke, heart failure. Reducing the severity of a patient’s heart failure "would give them back potentially many years of good quality life," said Mesoblast CEO Silviu Itescu. Joseph Woo, a heart surgeon at Stanford University and an investigator of the NIH trial, "this would be considered # one of the big advances of this century. But researchers were encouraged by patients treated up to 36 hours post stroke.

This reinforces and cements an efficient path forward for us," Athersys Chief Executive Gil Van Bokkelen said.Both have overcome major hurdles to manufacturing stem cell treatments on a large scale that are off-the-shelf products derived from healthy donor bone marrow and do not face immune system rejection issues. Both have overcome major hurdles to manufacturing stem cell treatments on a large scale that are off-the-shelf products derived from healthy donor bone marrow and do not face immune system rejection issues.2 billion cells delivered via simple intravenous drip - dampens the immune system’s hyper-inflammatory reaction to signals that the brain is under attack during stroke, and promotes healing.That trial, attempting to extend the treatment window to 48 hours, failed.Mesoblast’s MPC-150-IM therapy aims to mitigate advanced heart failure, a progressive condition in which the heart cannot pump enough blood to efficiently serve the body. "The market tends to test these companies sometimes to the brink," said Tom Dobell, who manages a fund for U. Thomas Carmichael, co-director of UCLA Broad Stem Cell Center, who was not involved in Multistem trials."M&G is a long-time holder of Mesoblast, with about a 15 percent stake, and Athersys, with about 4 percent. S.Some 250,000 people in the United States alone have been diagnosed with most serious class IV heart failure, and only about 9,000 receive a transplant or left ventricular assist device (LVAD) each year, Itescu said.

We’re comfortable that the progress that’s going on is going to be worth it.The company plans to begin a 300-patient Phase III study of Multistem in early 2018, aiming for US and European approval after regulators agreed to protocols for one pivotal trial. "Its reason to be cautiously optimistic," said Dr.An ongoing Phase III trial of 600 advanced heart failure patients is currently enrolling.Perception of the field has also been hurt by unscrupulous actors selling unapproved, possibly unsterile cell therapies for everything from cancer to lung disease and ALS, prompting a US crackdown this past summer.Cleveland-based Athersys, with a market value of about $200 million, demonstrated evidence in a mid-stage trial that its therapy may be able to expand the emergency treatment window for major strokes to up to 36 hours, compared with about four hours with current drugs, potentially allowing many more patients to avoid crippling disabilities.The body’s reaction to stroke may also severely deplete the immune system, leading to later complications beyond paralysis or speech impairment.Athersys believes Multistem - 1.Independent monitors who oversee and can halt blinded clinical trials for futility gave a green light to continue the Mesoblast study in April after a review of the first 270 treated patients, suggesting the therapy might be effective. A separate 220-patient Multistem trial in Japan for that market began enrolling patients through partner Healios KK.A separate US National Institutes of Health-sponsored Phase II study of 159 end-stage heart failure patients dependent on an implanted pumping assist device completed enrolment in September, with results expected in the first quarter of 2018.The company believes the therapy reduces inflammation, increases blood flow and spurs blood vessel formation that helps repair the heart muscle.They are among the farthest along in the stem cell industry at a time when Wall Street investors have focused on potentially big payoffs from immune-system based cancer therapies and rare disease treatments.Australia’s Mesoblast, with a market value of about $500 million, is attempting to alter advanced heart failure, a leading cause of hospitalizations and deaths and an enormous cost burden.If such patients can recover enough to again rely on their own heart, said Dr. A single dose consists of 150 million highly purified stem cells delivered directly to the heart’s left ventricle by injection or catheter. (Photo: AFP) New York: The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes have given way to a long list of failures, highlighted by early stem cell champion Geron Corp abandoning the field in 2011.-based M&G Investment Management that specializes in supporting promising companies during difficult periods. "Of the many entities in this field, they have been careful and deliberate in their movement forward" and do not engage in "overwrought claims," said Dr.But two small companies, Athersys Inc and Mesoblast Ltd, are beginning final stage trials in hundreds of patients that they - along with loyal investors - say could change the course of devastating stroke and heart failure. In the Phase II trial, Multistem patients had significantly fewer incidents of pneumonia, acute pulmonary distress and other serious complications.K

Hide Comments | Add Comment

Posted by: Dorris at November 16, 2023 12:51 PM (EINHM)

Hide Comments | Add Comment